99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid

China 99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid, Find details about China Linezolid, Material Linezolid from 99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid

Model NO.
D-sung Linezolid
Product Name
Linezolid
Name
Linezolid Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical;Antipyretic
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
165800-03-3
Mf
C16h20fn3o4
MW
337.351
Boiling Point
585.5 Oc at 760 Mmhg
Density
1.302
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
Model NO.
D-sung Linezolid
Product Name
Linezolid
Name
Linezolid Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical;Antipyretic
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
165800-03-3
Mf
C16h20fn3o4
MW
337.351
Boiling Point
585.5 Oc at 760 Mmhg
Density
1.302
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid
99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid
Product Description
99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid
Product Details
99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid
Product name Linezolid
AppearanceWhite powder
Cas number165800-03-3
MFC16H20FN3O4
MW337.351
Linezolid is a antibiotic used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to other antibiotics. Linezolid is active against most Gram-positive bacteria that cause disease, including streptococci, vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA). The main uses are infections of the skin and pneumonia although it may be use for a variety of other infections.As a protein synthesis inhibitor, it stops the growth of bacteria by disrupting their production of proteins, that is, it is a bacteriostatic agent, not bacteriocidal. Although many antibiotics work this way, the exact mechanism of action of linezolid appears to be unique in that it blocks the initiation of protein production, and not one of the later steps. Bacterial resistance to linezolid has remained very low since it was first detected in 1999, although it may be increasing. It is a member of the oxazolidinone class of drugs.
Application&Function
99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material LinezolidThe main indication of linezolid is the treatment of severe infections caused by Gram-positive bacteria that are resistant to other antibiotics; it should not be used against bacteria that are sensitive to drugs with a narrower spectrum of activity, such as penicillins and cephalosporins. In both the popular press and the scientific literature, linezolid has been called a "reserve antibiotic"-one that should be used sparingly so that it will remain effective as a drug of last resort against potentially intractable infections.
In the United States, the indications for linezolid use approved by the U.S. Food and Drug Administration (FDA) are the treatment of vancomycin-resistant Enterococcus faecium infections, with or without bacterial invasion of the bloodstream; nosocomial pneumonia (hospital-acquired) and community-acquired pneumonia caused by S. aureus or S. pneumoniae; complicated skin and skin structure infections (cSSSI) caused by susceptible bacteria, including diabetic foot infection, unless complicated by osteomyelitis (infection of the bone and bone marrow); and uncomplicated skin and soft tissue infections caused by S. pyogenes or S. aureus.The manufacturer advises against the use of linezolid for community-acquired pneumonia or uncomplicated skin and soft tissue infections caused by MRSA.In the United Kingdom, pneumonia and cSSSIs are the only indications noted in the product labeling.
Specification
99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid
99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid
99% CAS 165800-03-3 Linezolid API Purity Linezolid Powder Raw Material Linezolid